Ensign Peak Advisors
HRMY icon

Ensign Peak Advisors’s Harmony Biosciences HRMY Stock Holding History

Ensign Peak Advisors’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$129K Hold
3,535
– – ﹤0.01% 1548
2026
Q1 		$99K Hold
3,535
– – ﹤0.01% 1569
2025
Q4 		$132K Sell
3,535
-9,850
-74% -$324K ﹤0.01% 1480
2025
Q3 		$369K Hold
13,385
– – ﹤0.01% 1514
2025
Q2 		$423K Hold
13,385
– – ﹤0.01% 1598
2025
Q1 		$444K Hold
13,385
– – ﹤0.01% 1578
2024
Q4 		$461K Hold
13,385
– – ﹤0.01% 1621
2024
Q3 		$535K Hold
13,385
– – ﹤0.01% 1588
2024
Q2 		$404K Hold
13,385
– – ﹤0.01% 1649
2024
Q1 		$449K Sell
13,385
-675
-5% -$21.7K ﹤0.01% 1645
2023
Q4 		$454K Buy
14,060
+2,350
+20% +$65.6K ﹤0.01% 1674
2023
Q3 		$384K Hold
11,710
– – ﹤0.01% 1651
2023
Q2 		$412K Hold
11,710
– – ﹤0.01% 1671
2023
Q1 		$382K Buy
11,710
+300
+3% +$13.7K ﹤0.01% 1685
2022
Q4 		$629K Buy
11,410
+7,150
+168% +$393K ﹤0.01% 1527
2022
Q3 		$189K Buy
4,260
+880
+26% +$42.9K ﹤0.01% 1894
2022
Q2 		$165K Hold
3,380
– – ﹤0.01% 1850
2022
Q1 		$164K Buy
3,380
+3,090
+1,066% +$126K ﹤0.01% 1932
2021
Q4 		$12K Buy
+290
New +$11.6K ﹤0.01% 2188

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ensign Peak Advisors's HRMY Position: Q2 2026 in Review

Ensign Peak Advisors held its Harmony Biosciences (HRMY) position steady in Q2 2026 at 3,535 shares worth $129K. The position accounts for ﹤0.01% of the portfolio, ranked #1548.

Ensign Peak Advisors first reported a position in HRMY in Q4 2021 and has held it in 19 quarters since. The position peaked at $629K in Q4 2022. 328 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Ensign Peak Advisors held 3,535 shares of Harmony Biosciences worth $129K as of Q2 2026.
  • Ensign Peak Advisors left its Harmony Biosciences share count unchanged in Q2 2026.
  • Harmony Biosciences made up ﹤0.01% of Ensign Peak Advisors's portfolio in Q2 2026, its #1548 holding.
  • Ensign Peak Advisors first reported a position in Harmony Biosciences in Q4 2021 and has held it in 19 quarters since.
  • Ensign Peak Advisors's Harmony Biosciences position peaked at $629K in Q4 2022.
  • 328 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Ensign Peak Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.